TScan Therapeutics, Inc. (TCRX)
NASDAQ: TCRX · Real-Time Price · USD
0.969
+0.129 (15.33%)
At close: Jun 26, 2026, 4:00 PM EDT
0.885
-0.084 (-8.64%)
After-hours: Jun 26, 2026, 6:54 PM EDT
TScan Therapeutics Stock Forecast
Stock Price Forecast
The 4 analysts with 12-month price forecasts for TScan Therapeutics stock have an average target of 6.00, with a low estimate of 5.00 and a high estimate of 7.00. The average target predicts an increase of 519.32% from the current stock price of 0.97.
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for TScan Therapeutics stock from 6 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Dec '25 | Feb '26 | Mar '26 | Apr '26 | May '26 | Jun '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 4 | 4 | 4 | 4 | 4 | 4 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 2 | 1 | 1 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 7 | 6 | 6 | 6 | 6 | 6 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Morgan Stanley | Morgan Stanley | Hold Maintains n/a | Hold | Maintains | n/a | n/a | Jun 23, 2026 |
| LifeSci Capital | LifeSci Capital | Buy Maintains $6 | Buy | Maintains | $6 | +519.32% | Jun 23, 2026 |
| Needham | Needham | Buy Reiterates $6 | Buy | Reiterates | $6 | +519.32% | Jun 23, 2026 |
| H.C. Wainwright | H.C. Wainwright | Buy Reiterates $7 | Buy | Reiterates | $7 | +622.54% | Jun 23, 2026 |
| Wedbush | Wedbush | Buy Maintains $5 | Buy | Maintains | $5 | +416.10% | Jun 23, 2026 |
Financial Forecast
Revenue This Year
7.56M
from 10.33M
Decreased by -26.80%
Revenue Next Year
7.81M
from 7.56M
Increased by 3.30%
EPS This Year
-0.84
from -1.00
EPS Next Year
-0.89
from -0.84
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 10.8M | 11.4M | |
| Avg | 7.6M | 7.8M | |
| Low | 982,000 | n/a |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 5.0% | 50.6% | |
| Avg | -26.8% | 3.3% | |
| Low | -90.5% | -100.0% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | - | - | |
| Avg | -0.84 | -0.89 | |
| Low | - | - |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | - | - | |
| Avg | - | - | |
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.